LOWV vs. IMOM ETF Comparison
Comparison of AB US Low Volatility Equity ETF (LOWV) to International Quantitative Momentum ETF (IMOM)
LOWV
AB US Low Volatility Equity ETF
LOWV Description
The fund is an actively-managed exchange-traded fund ("ETF"). The adviser seeks to achieve the fund"s investment objective by investing, under normal circumstances, at least 80% of its net assets in the equity securities of U.S. companies. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$71.64
Average Daily Volume
7,408
Number of Holdings
*
74
* may have additional holdings in another (foreign) market
IMOM
International Quantitative Momentum ETF
IMOM Description
The investment seeks long-term capital appreciation. Under normal circumstances, the fund seeks to achieve its investment objective by investing primarily-generally greater than 80%, but at least 65% of its net assets, plus any borrowings for investment purposes-in equity securities of international companies that Empowered Funds, LLC ("the Adviser") believes, based on quantitative analysis, have positive momentum. A "momentum" style of investing emphasizes investing in securities that have had higher recent total return performance compared to other securities. It is non-diversified.Grade (RS Rating)
Last Trade
$27.83
Average Daily Volume
5,405
Number of Holdings
*
6
* may have additional holdings in another (foreign) market
Performance
Period | LOWV | IMOM |
---|---|---|
30 Days | 1.62% | 0.91% |
60 Days | 2.39% | -4.00% |
90 Days | 4.17% | -2.66% |
12 Months | 24.87% | 10.56% |
1 Overlapping Holdings
Symbol | Grade | Weight in LOWV | Weight in IMOM | Overlap | |
---|---|---|---|---|---|
ABBV | D | 2.05% | 2.0% | 2.0% |
LOWV Overweight 73 Positions Relative to IMOM
Symbol | Grade | Weight | |
---|---|---|---|
MSFT | F | 8.14% | |
GOOG | C | 4.91% | |
AAPL | C | 3.95% | |
AVGO | D | 3.28% | |
FI | A | 2.47% | |
ORCL | B | 2.33% | |
NVDA | C | 2.24% | |
UNH | C | 2.09% | |
V | A | 1.96% | |
PM | B | 1.91% | |
AMZN | C | 1.91% | |
MCK | B | 1.74% | |
MRK | F | 1.73% | |
ADP | B | 1.73% | |
INTU | C | 1.7% | |
META | D | 1.64% | |
JPM | A | 1.59% | |
AZO | C | 1.49% | |
ADBE | C | 1.41% | |
MMC | B | 1.34% | |
KO | D | 1.34% | |
AEP | D | 1.33% | |
GILD | C | 1.26% | |
CMCSA | B | 1.26% | |
BAC | A | 1.23% | |
MA | C | 1.18% | |
NOW | A | 1.17% | |
LHX | C | 1.14% | |
DOX | D | 1.14% | |
PG | A | 1.11% | |
CBOE | B | 1.1% | |
LULU | C | 1.08% | |
G | B | 1.06% | |
EG | C | 1.05% | |
SHW | A | 1.02% | |
ACM | A | 0.96% | |
CI | F | 0.96% | |
BKNG | A | 0.96% | |
NYT | C | 0.9% | |
LLY | F | 0.89% | |
EA | A | 0.89% | |
YUM | B | 0.89% | |
VRTX | F | 0.86% | |
MDT | D | 0.85% | |
RELX | C | 0.83% | |
WMT | A | 0.82% | |
GEN | B | 0.81% | |
WTW | B | 0.79% | |
PGR | A | 0.79% | |
AEE | A | 0.77% | |
NTAP | C | 0.74% | |
PSA | D | 0.73% | |
ETN | A | 0.66% | |
XOM | B | 0.66% | |
LMT | D | 0.64% | |
DLB | B | 0.64% | |
MSCI | C | 0.63% | |
MTB | A | 0.61% | |
ADI | D | 0.6% | |
RGA | A | 0.6% | |
AMAT | F | 0.6% | |
LDOS | C | 0.55% | |
CL | D | 0.54% | |
AFG | A | 0.5% | |
ORLY | B | 0.48% | |
TSM | B | 0.48% | |
PAYX | C | 0.46% | |
SPGI | C | 0.41% | |
FR | C | 0.39% | |
CRM | B | 0.33% | |
NICE | C | 0.29% | |
TMO | F | 0.29% | |
VZ | C | 0.22% |
LOWV: Top Represented Industries & Keywords
Industries:
Software - Application
Business Services
Drug Manufacturers - Major
Semiconductors
Software - Infrastructure
Specialty Retail
Banks - Global
Capital Markets
Credit Services
Health Care Plans
Household & Personal Products
Insurance - Property & Casualty
Insurance - Reinsurance
Insurance Brokers
Internet Content & Information
Publishing
REIT - Industrial
Utilities - Regulated Electric
Aerospace & Defense
Apparel Stores
IMOM: Top Represented Industries & Keywords
Industries:
Banks - Regional - Europe
Drug Manufacturers - Major
Drug Manufacturers - Specialty & Generic
Electronic Gaming & Multimedia
Marine Shipping
Software - Infrastructure
Keywords:
Immunosuppressants
Pharmaceutical
Active Pharmaceutical Ingredients
Adalimumab
Advanced Prostate Cancer
Allergy
Anemia
Asset Finance
Asset Management
Asthma
Atopic Dermatitis
Autoimmune Disease
Bancassurance
Banking
Birth Control
Blood Cancers
Blood Cells
Bronchial Asthma
Cancer
Chemical Entities